Shaimaa Hamza
Kazan, TA, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Implications of NLRP3 Suppression Using Glibenclamide and miR-223 against Colorectal Cancer.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 30, 2023
Cross-reactivity of hantavirus antibodies after immunization with PUUV antigens.
Journal: Biotechnology and applied biochemistry
Published: November 29, 2023
Identification of conserved immunogenic peptides of SARS-CoV-2 nucleocapsid protein.
Journal: Journal of biomolecular structure & dynamics
Published: September 26, 2023
Neutralizing Antibodies in COVID-19 Serum from Tatarstan, Russia.
Journal: International journal of molecular sciences
Published: May 08, 2023
Blocking the Hormone Receptors Modulates NLRP3 in LPS-Primed Breast Cancer Cells.
Journal: International journal of molecular sciences
Published: December 30, 2022
Azithromycin and Ceftriaxone Differentially Activate NLRP3 in LPS Primed Cancer Cells.
Journal: International journal of molecular sciences
Published: July 29, 2022
Antibody and T Cell Immune Responses to SARS-CoV-2 Peptides in COVID-19 Convalescent Patients.
Journal: Frontiers in microbiology
Published: December 23, 2021
Immunogenic SARS-CoV-2 S and N Protein Peptide and Cytokine Combinations as Biomarkers for Early Prediction of Fatal COVID-19.
Journal: Frontiers in immunology
Published: December 07, 2021
Long Term Immune Response Produced by the SputnikV Vaccine.
Journal: International journal of molecular sciences
Published: August 31, 2021
Doxycycline Attenuates Cancer Cell Growth by Suppressing NLRP3-Mediated Inflammation.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 28, 2021
Therapeutic Potential of Pharmacological Targeting NLRP3 Inflammasome Complex in Cancer.
Journal: Frontiers in immunology
Published: September 18, 2020
Last Updated: 09/26/2026